WYETH-AYERST'S LODINE APPROVED FOR TREATMENT OF OSTEOARTHRITIS AND PAIN RELIEF; TWICE-DAILY ANTIARTHRITIC WILL ENTER CROWDED NSAID MARKET THIS SPRING